Table 2.
N | ADC values (×10−3) | p | |
Tumour type | |||
IDC | 48 | 0.988 (0.108–1.520) | 0.867 |
ILC | 6 | 1.081 (0.155–1.300) | |
Other | 7 | 0.874 (0.686–1.630) | |
Tumour grade | |||
Grade 1 | 7 | 1.190 (0.108–1.630) | 0.485 |
Grade 2 | 21 | 1.020 (0.155–1.410) | |
Grade 3 | 28 | 0.979 (0.108–1.630) | |
Ki-67 | |||
Negative | 22 | 1.045 (0.108–1.630) | 0.080 |
Positive | 39 | 0.965 (0.569–1.520) | |
Oestrogen receptors | |||
Negative | 11 | 0.970 (0.108–1.430) | 0.632 |
Positive | 50 | 0.993 (0.155–1.630) | |
Progesterone receptors | |||
Negative | 18 | 0.968 (0.108–1.630) | 0.658 |
Positive | 43 | 1.010 (0.155–1.520) | |
C-erb B2 | |||
0 | 35 | 1.020 (0.108–1.630) | 0.859 |
1 | 9 | 0.940 (0.874–1.290) | |
2 | 3 | 0.850 (0.834–1.090) | |
3 | 14 | 0.980 (0.569–1.520) | |
Lymphovascular Invasion | |||
Negative | 40 | 1.001 (0.155–1.630) | 0.154 |
Positive | 21 | 0.951 (0.108–1.360) | |
Component | |||
Absent | 16 | 0.893 (0.108–1.630) | 0.187 |
DCIS | 37 | 0.993 (0.569–1.520) | |
LCIS | 8 | 1.040 (0.155–1.300) |
ADC values given as median (minimum–maximum). ADC, apparent diffusion coefficient; DCIS, ductal carcinoma in situ; LCIS, lobular carcinoma in situ; IDC, invasive ductal carcinoma; ILC, invasive lobular carcinoma